Back
Speaker illustration

Miss Elsa Silva

I3s (Institute for Research and Innovation in Health), Porto (Portugal)

Presentations

Pharmacological Targeting of Senescence with ABT-263 in Experimental Heart Failure with Preserved Ejection Fraction

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Heart Failure

Session: Moderated poster 10 - Heart Failure

Access
Like
Thumbnail

The senolyitc drug ABT-263 reverses HFpEF-associated inflammation, endothelial inflammation and fibrosis

Event: Heart Failure 2021

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic Heart Failure - Pathophysiology and Mechanisms 2

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources